Semaglutide Linked to 20% Fewer COPD Flare-Ups and Nearly 40% Fewer Asthma Attacks

GLP-1 treatment linked to 40% fewer asthma attacks

The diabetes and weight loss injection semaglutide can reduce asthma attacks by up to 40 per cent according to research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

People with asthma who take semaglutide have fewer attacks, study shows

Connection to reduced asthma or COPD flare-ups was stronger with higher doses of the drug, study found

Semaglutide linked to 20% fewer COPD flare-ups and nearly 40% fewer asthma attacks

The diabetes and weight-loss injection semaglutide can reduce asthma attacks by up to 40%, according to research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain. The study was led by Chloe Bloom, clinical associate professor in respiratory epidemiology at the National Heart & Lung Institute, Imperial College London, UK, and presented by Dr. Bohee Lee.

expert reaction to unpublished study about semaglutide and asthma attacks in people with diabetes, as presented at the European Respiratory Society Congress

Scientists comment on an unpublished study presented at the European Respiratory Society Congress about semaglutide and asthma attacks in people with diabetes    Dr Marie Spreckley, Researcher on the Prevention of Diabetes and Related Metabolic Disorders at the University of Cambridge, said: “The title ‘semaglutide can reduce asthma attacks’ makes a causal claim that is not supported by this observational study. The study identifies an associat…

People with asthma who take weight loss drug semaglutide have fewer attacks, study shows

Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting […]